Mechanism of the reprogramming of gene expression in mammalian oocytes
哺乳动物卵母细胞基因表达重编程机制
基本信息
- 批准号:14360164
- 负责人:
- 金额:$ 9.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this research project is to clarify the mechanism of reprogramming of gene expression in the oocytes before and/or after fertilizaion. Since the gene expression patterns of differentiated cells are maintained by the mechanism of "cell memory" during mitosis and those in the oocytes are reprogrammed into the ones in the totopotent embryos, we postulated that erasing the cell memory is involved in the reprogramming of gene expression by initializing the program.We examined histone acetylations in the oocytes and embryos as a candidate marker of cell memory. Immunocytochemistry with specific antibody against various lysine residues of histories revealed that acetylation of histones was maintained during mitosis in the preimplantaion embryos after fertilization as well as somatic cells but that it disappeared in the oocytes when they resumed meiosis and this deacetylated state was maintained until metaphase II (MII). Since it has been shown that the the gene expression pattern is reprogrammed when the somatic nuclei transferred into MII stage oocytes, we examined histone acetylation in these nuclei. The results showed that all lysine residues examined were deacetylated after transplantation. These results suggested that global histone deacetylation is involved in the reprogramming of gene expression in the oocytes.This meiosis-specific histone deacetylation seemed to be induced by the association of histone deacetylase I (HDAC1) with meiotic chromosomes, since HDAC1 was co-localized with chromosomes during meiosis but not mitosis. Finally, we showed that histone deacetylation is regulated by p34^<cdc2> protein kinase during meiosis.
本研究旨在阐明受精前后卵母细胞基因表达重编程的机制。由于分化细胞的基因表达模式是通过有丝分裂过程中的“细胞记忆”机制来维持的,并且卵母细胞中的基因表达模式被重新编程为全发育胚胎中的基因表达模式,因此我们假设,通过初始化程序来消除细胞记忆参与了基因表达的重新编程,我们检测了卵母细胞和胚胎中的组蛋白乙酰化作为细胞记忆的候选标记。用特异性抗体对不同赖氨酸残基的免疫细胞化学显示,在受精后的胚胎和体细胞中,组蛋白的乙酰化在有丝分裂过程中得以维持,但当卵母细胞恢复减数分裂时,组蛋白的乙酰化消失,这种去乙酰化状态一直维持到中期II(MII)。由于已经表明,当体细胞核转移到MII期卵母细胞中时,基因表达模式被重编程,因此我们检测了这些细胞核中的组蛋白乙酰化。结果表明,所有检测的赖氨酸残基在移植后均被脱乙酰化。这些结果表明,组蛋白去乙酰化参与了卵母细胞基因表达的重编程,这种减数分裂特异性的组蛋白去乙酰化可能是由组蛋白去乙酰化酶I(HDAC 1)与减数分裂染色体的结合所诱导的,因为HDAC 1在减数分裂中与染色体共定位,而在有丝分裂中不与染色体共定位。最后,我们发现在减数分裂过程中,组蛋白去乙酰化受p34^<cdc2>蛋白激酶的调节。
项目成果
期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Liu, H., Aoki, F.: "Meiotic competence of mouse oocytes reconstructed by replacing the germinal vesicle with a male pronucleus and somatic nucleus."Anim.Sci.J.. (in press). (2004)
Liu, H., Aoki, F.:“通过用雄性原核和体细胞核取代生发囊泡来重建小鼠卵母细胞的减数分裂能力。”Anim.Sci.J.(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Isolation of nascent mRNA from mouse preimplantation embryos.
从小鼠植入前胚胎中分离新生 mRNA。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kageyama S;Nagata M;Aoki F
- 通讯作者:Aoki F
Cho, T., Sakai, S., Nagata, M., Aoki, F.: "Involvement of chromatin structure in the regulation of mouse zygotic gene activation"Anim. Sci. J.. 73・1. 113-122 (2002)
Cho,T.,Sakai,S.,Nagata,M.,Aoki,F.:“染色质结构参与小鼠合子基因激活的调节”J.. 73・122(2002) )
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Aoki, F., Hara, T.K., Schultz, R.M.: "Acquisition of transcriptional competence in the 1-cell mouse embryo : requirement for recruitment of maternal mRNAs"Mol. Reprod. Dev.. 64・3. 270-274 (2003)
Aoki, F., Hara, T.K., Schultz, R.M.:“1 细胞小鼠胚胎中转录能力的获得:母体 mRNA 募集的要求”Mol Dev. 64・3 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Involvement of chromatin structure in the regulation of mouse zygotic gene activation.
- DOI:10.1046/j.1344-3941.2002.00017.x
- 发表时间:2002-01-01
- 期刊:
- 影响因子:2
- 作者:Cho, T.;Sakai, S.;Aoki, F.
- 通讯作者:Aoki, F.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AOKI Fugaku其他文献
1細胞期胚の雌雄前核におけるヒストンH3変異体の非対称的局在について.
组蛋白 H3 突变体在单细胞期胚胎雄性和雌性原核中的不对称定位。
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
FUNAYA Satoshi;AOKI Fugaku;青木不学;青木不学 - 通讯作者:
青木不学
AOKI Fugaku的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AOKI Fugaku', 18)}}的其他基金
Involvement of histone variants in the reprogramming of gene expression before and after fertilization
组蛋白变异参与受精前后基因表达的重编程
- 批准号:
18H03970 - 财政年份:2018
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Identification and analysis for the function of maternal factors using CRISPR/Cas system
利用CRISPR/Cas系统鉴定和分析母源因子的功能
- 批准号:
26660246 - 财政年份:2014
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Involvement of maternal mRNA in the regulation of differentiation during preimplantation development.
母体 mRNA 参与植入前发育过程中分化的调节。
- 批准号:
24658244 - 财政年份:2012
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Mechanism for the acquisition of totipotency by Yamanaka factors
山中因子获得全能性的机制
- 批准号:
22658091 - 财政年份:2010
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Acquisition of the meiotic and mitotic competence during oocyte growth
卵母细胞生长过程中减数分裂和有丝分裂能力的获得
- 批准号:
22380156 - 财政年份:2010
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mechanism for the reprogramming of gene expression in the oocytes and preimplantation embryos
卵母细胞和植入前胚胎基因表达重编程机制
- 批准号:
17380166 - 财政年份:2005
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of zygotic gene activation in mammals.
哺乳动物合子基因激活的调节。
- 批准号:
10660266 - 财政年份:1998
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
- 批准号:82370797
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
- 批准号:82370920
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
调控拟南芥体细胞再生关键基因的鉴定
- 批准号:32000507
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
中性粒细胞在体内条件下重编程为造血干祖细胞的研究
- 批准号:92068101
- 批准年份:2020
- 资助金额:80.0 万元
- 项目类别:重大研究计划
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
- 批准号:92068107
- 批准年份:2020
- 资助金额:79.0 万元
- 项目类别:重大研究计划
m6A识别蛋白YTHDFs在体细胞重编程中的调控作用及机制研究
- 批准号:32000501
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人干细胞分化和重编程过程中的R-环变化规律研究
- 批准号:32000500
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
- 批准号:32000502
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
小分子化合物促进肝细胞增殖和肝脏再生的研究
- 批准号:32000504
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转录因子剂量效应调控体细胞重编程的表观遗传机制研究
- 批准号:31970681
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
CCA's lineage heterogeneity and subsequent adaptive reprogramming upon acquired resistant to CDK4/6 inhibitor.
CCA 的谱系异质性以及随后获得对 CDK4/6 抑制剂耐药性后的适应性重编程。
- 批准号:
24K18491 - 财政年份:2024
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improving Functional Regeneration and Engraftment of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells by Brief Cycles of Transient Reprogramming
通过短暂的瞬时重编程周期改善人诱导多能干细胞来源的心肌细胞的功能再生和植入
- 批准号:
24K11267 - 财政年份:2024
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Selectively Reprogramming Proteases through the High-Throughput Discovery of Functional Protein-Protein Interactions.
职业:通过功能性蛋白质-蛋白质相互作用的高通量发现选择性地重编程蛋白酶。
- 批准号:
2237629 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Continuing Grant
Injury Reprogramming at the Root of Glioblastoma Initiation and Progression
胶质母细胞瘤发生和进展根源的损伤重编程
- 批准号:
495808 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Operating Grants
Elucidation of tumor development mechanism by immune escape mechanism through metabolic reprogramming of anticancer drug-resistant cancer
通过抗癌药物耐药性癌症的代谢重编程的免疫逃逸机制阐明肿瘤发生机制
- 批准号:
23K18344 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Discovery of safe and effective gene targets for cellular reprogramming therapies
发现细胞重编程疗法安全有效的基因靶点
- 批准号:
10064114 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Collaborative R&D
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Reversal of Ovarian Aging in Mice Through AAV-mediated Oocyte Reprogramming in vivo
通过 AAV 介导的体内卵母细胞重编程逆转小鼠卵巢衰老
- 批准号:
10723227 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
- 批准号:
10714384 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Metabolic Control of Epigenetic Reprogramming in Neovascularization
新血管形成中表观遗传重编程的代谢控制
- 批准号:
10605418 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别: